Continuous Metabolic Monitoring Wearables

CGMs were designed for diabetics but Stanford lab found CGM data identifies prediabetes 3 to 4 years before HbA1c tests. Abbott FreeStyle Libre 3 and Dexcom G7 last 14 days with smartphone integration. Glycemic variability in non-diabetics correlates with cardiovascular risk and cognitive decline. By 2028 CGMs are expected to reach 15 million non-diabetic users globally as preventive medicine tools.